
Marin Jukić
Co-founder and Chief Officer of the startup TDM - Personalized Pharmacotherapy
Marin Jukić graduated from the Mathematical Gymnasium in 2004 and earned his Master of Pharmacy degree from the Faculty of Pharmacy in Belgrade in 2010. He completed his PhD in neuroscience at Ben Gurion University in Israel in 2014. Marin’s research focuses on the neurobiology of emotions, psychiatric disorders, and the personalization of pharmacotherapy. The projects he has worked on have secured over two million dollars in funding for the research groups he has led. He has published eight studies in high-impact journals, and his work has been awarded three times at the University of Belgrade. His most significant achievement includes influencing the FDA's dosing recommendations for the antidepressant escitalopram and revising the metabolizer classification for the enzyme CYP2D6. Additionally, in 2024, he founded the startup TDM - Personalized Pharmacotherapy.
Nazad na stranu Govornici
Ostali govornici
























































































































































